Cargando…

Antipsychotic-induced catatonia and neuroleptic malignant syndrome: the dark side of the moon

Detalles Bibliográficos
Autores principales:	Hirjak, Dusan, Sartorius, Alexander, Kubera, Katharina M., Wolf, Robert Christian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8760068/ https://www.ncbi.nlm.nih.gov/pubmed/34012038 http://dx.doi.org/10.1038/s41380-021-01158-2

Ejemplares similares

Neuroleptic malignant syndrome following catatonia: Vigilance is the price of antipsychotic prescription
por: Reilly, Thomas J, et al.
Publicado: (2017)

A Case of Catatonia and Neuroleptic Malignant Syndrome Probably Associated with Antipsychotic in Korea
por: Choi, Ho-Dong, et al.
Publicado: (2011)

Malignant Catatonia Versus Neuroleptic Malignant Syndrome
por: Desai, Saral, et al.
Publicado: (2021)

Neuroleptic Malignant Syndrome or Catatonia? A Case Report
por: Rodriguez, Sebastian, et al.
Publicado: (2020)

Malignant Catatonia and Neuroleptic Malignant Syndrome in Relation to Disulfiram Overdose
por: Kumar, Kiran K., et al.
Publicado: (2016)

Catatonia versus neuroleptic malignant syndrome: the diagnostic dilemma and treatment
por: Sahoo, Manoj Kumar, et al.
Publicado: (2014)

Intrinsic neural network dynamics in catatonia
por: Sambataro, Fabio, et al.
Publicado: (2021)

The dark side of the Moon
Publicado: (1998)

Different faces of catatonia and how to approach them
por: Hirjak, Dusan, et al.
Publicado: (2022)

Eclipse: journeys to the dark side of the Moon
por: Close, Frank
Publicado: (2017)

The Dark Side of the Moon: The Right Ventricle
por: Foschi, Massimiliano, et al.
Publicado: (2017)

Neuroleptic malignant syndrome following reintroduction of an antipsychotic after overdose
por: Korchia, Théo, et al.
Publicado: (2018)

Catatonic Symptoms Appearing before Autonomic Symptoms Help Distinguish Neuroleptic Malignant Syndrome from Malignant Catatonia
por: Komatsu, Takayuki, et al.
Publicado: (2016)

Anti-NMDA-receptor encephalitis presenting with catatonia and neuroleptic malignant syndrome in patients with intellectual disability and autism
por: Kiani, Reza, et al.
Publicado: (2015)

Catatonia, Neuroleptic Malignant Syndrome, and Cotard Syndrome in a 22-Year-Old Woman: A Case Report
por: Weiss, C., et al.
Publicado: (2013)

Cefepime-Induced Neurotoxicity Can Be Confused With Neuroleptic Malignant Syndrome, Catatonia and Serotonin Syndrome: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Vasopressor Therapy and the Brain: Dark Side of the Moon
por: Heming, Nicholas, et al.
Publicado: (2020)

Glaucomatous Optic Neuropathy: The Dark Side of the Moon
por: Yazdani, Shahin
Publicado: (2021)

Bias in Laboratory Medicine: The Dark Side of the Moon
por: Coskun, Abdurrahman
Publicado: (2024)

Neuroleptic Malignant Syndrome with Low Dose Lithium, Without Concomitant Antipsychotics
por: Ramadas, Smitha, et al.
Publicado: (2022)

The role of antipsychotics and other drugs on the development and progression of neuroleptic malignant syndrome
por: Kyotani, Yoji, et al.
Publicado: (2023)

Severe Recurrence of Neuroleptic Malignant Syndrome: Usefulness of Dexmedetomidine for Antipsychotic Withdrawal
por: Maeda, Keisuke, et al.
Publicado: (2023)

An Unusual Case of Neuroleptic Malignant Syndrome on a Stable Dose of Antipsychotic
por: Sanger, Emily, et al.
Publicado: (2023)

Neuroleptic malignant syndrome
por: Tan, Carolyn Michelle, et al.
Publicado: (2023)

A Case Report of Catatonia and Neuroleptic Malignant Syndrome With Multiple Treatment Modalities: Short Communication and Literature Review
por: Chiou, Yu-Jie, et al.
Publicado: (2015)

Two cases of neuroleptic malignant syndrome in elderly patients taking atypical antipsychotics
por: Feng, Yuhui, et al.
Publicado: (2013)

Emergent Treatment of Neuroleptic Malignant Syndrome Induced by Antipsychotic Monotherapy Using Dantrolene
por: Ngo, Vivian, et al.
Publicado: (2019)

NEUROLEPTIC MALIGNANT SYNDROME
por: Jayesh, Kanabar
Publicado: (1997)

Neuroleptic malignant syndrome
por: Rajamani, Bino, et al.
Publicado: (2016)

Second-Generation Antipsychotics and Neuroleptic Malignant Syndrome: Systematic Review and Case Report Analysis
por: Belvederi Murri, Martino, et al.
Publicado: (2015)

Rhabdomyolysis and Neuroleptic Malignant Syndrome Associated with Very Low-dose Antipsychotics in Children and Adolescent
por: Park, Jong-Il, et al.
Publicado: (2019)

Drug information update. Atypical antipsychotics and neuroleptic malignant syndrome: nuances and pragmatics of the association
por: Sarkar, Siddharth, et al.
Publicado: (2017)

Evaluation of neuroleptic malignant syndrome induced by antipsychotic drugs using spontaneous reporting system
por: Hirofuji, Sakiko, et al.
Publicado: (2023)

Endocrinology during internal medicine residency: The dark side of the moon
por: Chatterjee, Krishnarpan, et al.
Publicado: (2015)

Cardiotoxicity due to chemotherapy for breast cancer: The dark side of the moon
por: Peruzzi, Mariangela, et al.
Publicado: (2015)

Genetics and phenotypic heterogeneity of Dent disease: the dark side of the moon
por: Gianesello, Lisa, et al.
Publicado: (2020)

INCREASED RISK OF OCCURRENCE OF NEUROLEPTIC MALIGNANT SYNDROME ON COMBINED TREATMENT WITH LITHIUM AND NEUROLEPTIC
por: Alexander, P. John, et al.
Publicado: (1997)

Neuroleptic malignant syndrome induced by atypical neuroleptics and responsive to lorazepam
por: Yacoub, Adeeb, et al.
Publicado: (2006)

CHALLENGE WITH ATYPICAL ANTIPSYCHOTIC DRUGS IN RISPERIDONE INDUCED NEUROLEPTIC MALIGNANT SYNDROME: A CASE REPORT
por: Mendhekar, D.N., et al.
Publicado: (2002)

Neuroleptic Malignant Syndrome After Re-introduction of Atypical Antipsychotics in a COVID-19 Patient
por: Espiridion, Eduardo D, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dtigl5475pmmdp91816u0ogjes